PL3152226T3 - Modyfikowane cyklopentapeptydy i ich zastosowania - Google Patents

Modyfikowane cyklopentapeptydy i ich zastosowania

Info

Publication number
PL3152226T3
PL3152226T3 PL14733548T PL14733548T PL3152226T3 PL 3152226 T3 PL3152226 T3 PL 3152226T3 PL 14733548 T PL14733548 T PL 14733548T PL 14733548 T PL14733548 T PL 14733548T PL 3152226 T3 PL3152226 T3 PL 3152226T3
Authority
PL
Poland
Prior art keywords
cyclopentapeptides
modified
modified cyclopentapeptides
Prior art date
Application number
PL14733548T
Other languages
English (en)
Inventor
Hans-Jürgen Wester
Margret Schottelius
Theresa Osl
Andreas Poschenrieder
Marina Willibald
Original Assignee
Univ Muenchen Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Muenchen Tech filed Critical Univ Muenchen Tech
Publication of PL3152226T3 publication Critical patent/PL3152226T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/082—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being a RGD-containing peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL14733548T 2014-06-06 2014-06-06 Modyfikowane cyklopentapeptydy i ich zastosowania PL3152226T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2014/061875 WO2015185162A1 (en) 2014-06-06 2014-06-06 Modified cyclopentapeptides and uses thereof
EP14733548.3A EP3152226B1 (en) 2014-06-06 2014-06-06 Modified cyclopentapeptides and uses thereof

Publications (1)

Publication Number Publication Date
PL3152226T3 true PL3152226T3 (pl) 2019-10-31

Family

ID=51022816

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14733548T PL3152226T3 (pl) 2014-06-06 2014-06-06 Modyfikowane cyklopentapeptydy i ich zastosowania

Country Status (7)

Country Link
US (1) US10919938B2 (pl)
EP (1) EP3152226B1 (pl)
CN (1) CN106573959B (pl)
AU (1) AU2014396468B2 (pl)
HU (1) HUE044571T2 (pl)
PL (1) PL3152226T3 (pl)
WO (1) WO2015185162A1 (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI852183B (zh) 2011-12-28 2024-08-11 日商中外製藥股份有限公司 胜肽化合物之環化方法
US10815489B2 (en) 2015-03-13 2020-10-27 Chugai Seiyaku Kabushiki Kaisha Modified aminoacyl-tRNA synthetase and use thereof
KR102396324B1 (ko) * 2016-07-25 2022-05-09 위스콘신 얼럼나이 리서어치 화운데이션 인 시츄 면역 조절 암 백신화를 위한 표적화된 방사선요법 킬레이트
US12391971B2 (en) 2017-01-31 2025-08-19 Chugai Seiyaku Kabushiki Kaisha Method for synthesizing peptides in cell-free translation system
EP3636656A4 (en) 2017-06-09 2021-04-14 Chugai Seiyaku Kabushiki Kaisha METHOD OF SYNTHESIS OF PEPTIDE WITH N-SUBSTITUTED AMINO ACID
KR20230145543A (ko) * 2017-09-05 2023-10-17 메인라인 바이오사이언스 고친화성 cxcr4 선택적 결합 콘쥬게이트 및 그 사용 방법
US11123437B2 (en) * 2017-09-05 2021-09-21 Mainline Biosciences, Inc. Selective CXCR4 binding peptide conjugate and methods for making and using the same
US10639379B2 (en) * 2017-09-05 2020-05-05 Mainline Biosciences Llc High affinity CXCR4 selective binding conjugate and method for using the same
CN111479819B (zh) 2017-12-15 2024-06-14 中外制药株式会社 制备肽的方法和处理碱的方法
JP2021165234A (ja) * 2018-07-03 2021-10-14 富士フイルム富山化学株式会社 Ｃｘｃｒ４結合性化合物もしくはその塩またはそれらと金属との錯体
EA202190755A1 (ru) 2018-09-12 2021-06-11 Технише Универзитет Мюнхен Агенты для терапии и диагностики рака
CN119661653A (zh) 2018-09-12 2025-03-21 慕尼黑工业大学 具有降低的物种选择性的cxcr4靶向诊断和治疗剂
US12312297B2 (en) 2018-11-07 2025-05-27 Chugai Seiyaku Kabushiki Kaisha O-substituted serine derivative production method
CN119143631A (zh) 2018-11-30 2024-12-17 中外制药株式会社 用于肽化合物或酰胺化合物的脱保护方法和在固相反应中的树脂脱除方法以及用于生产肽化合物的方法
KR102994657B1 (ko) 2019-03-15 2026-07-22 추가이 세이야쿠 가부시키가이샤 방향족 아미노산 유도체의 제조 방법
EP4043478A4 (en) 2019-11-07 2024-01-03 Chugai Seiyaku Kabushiki Kaisha CYCLIC PEPTIDE COMPOUND HAVING KRAS INHIBITING ACTION
WO2021087568A1 (en) * 2019-11-08 2021-05-14 The University Of Queensland Radiolabelled targeting ligands
WO2021150258A1 (en) * 2020-01-26 2021-07-29 Mainline Biosciences Llc Isotopically labelled selective cxcr4 binding peptide conjugate and methods for making and using the same
CN116888138A (zh) 2020-11-30 2023-10-13 瑞择生物公司 放射性药物缀合组合物及其用途
EP4043041A1 (en) 2021-02-15 2022-08-17 Technische Universität München Cxcr4-ligands for diagnostic and therapeutic use and precursors thereof
CN114163499B (zh) * 2021-11-11 2024-08-02 浙江大学 一种神经钙粘蛋白抑制剂及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89222A (en) 1988-02-09 1995-03-30 Mallinckrodt Inc Preparation of metal-radionuclide-labelled proteins, certain novel compounds used therein and radiopharmaceutical compositions containing the labelled proteins
EP0885017A2 (en) 1996-02-27 1998-12-23 Mallinckrodt Medical, Inc. Use of labelled cck-b receptor ligands for the detection and localization of malignant human tumours
NO20004795D0 (no) * 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
WO2002042259A2 (en) 2000-11-27 2002-05-30 University Of Maryland, Baltimore Methods of synthesizing and using derivatives of [2-(2-aminoethoxy)ethoxy] acetic acid
JP5398945B2 (ja) * 2001-04-23 2014-01-29 マリンクロッド エルエルシー ＴｃおよびＲｅ標識放射活性グリコシル化オクトレオチド誘導体
WO2006017619A2 (en) * 2004-08-06 2006-02-16 The Regents Of The University Of California Receptor-binding cyclic peptides and methods of use
WO2007096662A2 (en) 2006-02-27 2007-08-30 Technische Universität München Cancer imaging and treatment
GB0603901D0 (en) * 2006-02-27 2006-04-05 Mallinckrodt Inc Cancer imaging and treatment
US8080659B2 (en) 2006-07-11 2011-12-20 Emory University CXCR4 antagonists including diazine and triazine structures for the treatment of medical disorders
GB0716897D0 (en) 2007-08-30 2007-10-10 Univ Muenchen Tech Cancer imaging and treatment
EP2100900A1 (en) 2008-03-07 2009-09-16 Universitätsspital Basel Bombesin analog peptide antagonist conjugates
WO2009134382A2 (en) 2008-04-30 2009-11-05 Siemens Medical Solutions Usa, Inc. Cyclopeptides containing rgd mimetics as imaging markers for integrins
EP2380596A1 (en) * 2010-04-20 2011-10-26 Technische Universität München Cyclopentapeptide derivatives and uses thereof
EP2380597A1 (en) * 2010-04-20 2011-10-26 Technische Universität München Cyclopeptide derivatives and uses thereof

Also Published As

Publication number Publication date
US10919938B2 (en) 2021-02-16
EP3152226A1 (en) 2017-04-12
AU2014396468A1 (en) 2016-12-01
WO2015185162A1 (en) 2015-12-10
HUE044571T2 (hu) 2019-11-28
CN106573959B (zh) 2022-03-25
US20180037608A1 (en) 2018-02-08
AU2014396468B2 (en) 2019-02-21
CN106573959A (zh) 2017-04-19
EP3152226B1 (en) 2019-05-29

Similar Documents

Publication Publication Date Title
IL252216B (en) Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines
IL247014A0 (en) 6-heteroaryloxy and 6-aryloxy-quinoline-2-carboxamides and their use
IL252804B (en) Anti-c10orf54 antibodies and their use
IL251248A0 (en) Anti-interleukin-33 antibodies and their uses
IL259367B (en) Promoters and their uses
IL249186A0 (en) Anti-cd20 glycoantibodies and their uses
IL247407B (en) Antibodies against egfrviii and their uses
IL246755A0 (en) The heteroaryls and their use
HUE044571T2 (hu) Módosított ciklopentapeptidek és alkalmazásaik
IL251001B (en) Anti-il-25 antibodies and their uses
GB201401617D0 (en) Novel combination and use
SI3233105T1 (sl) Nove kombinacije in uporaba
ZA201801052B (en) Combinations and uses thereof
SG11201704473WA (en) New methods and uses
IL251335A0 (en) Piperidinylpyrazolopyrimidinones and their use
IL254241A0 (en) Etv2 and its uses
GB201408091D0 (en) Methods and uses
PL3229772T3 (pl) 6-arylo-9-glikozylopuryny i ich zastosowanie
GB201416086D0 (en) Methods and uses
GB201416073D0 (en) Methods and uses
PT2923578T (pt) Método para a produção de um produto alimentar
GB201404728D0 (en) Disc-over incorporating disc-heads and disc-earning
GB201407596D0 (en) New compounds and uses
GB201407599D0 (en) New compounds and uses
GB201402467D0 (en) New Compounds and uses